Cargando…

Donor and Recipient Plasma Follistatin Levels are Associated with Acute Graft-versus-Host Disease in Blood and Marrow Transplant Clinical Trials Network 0402

Follistatin is an angiogenic factor elevated in the circulation after allogeneic hematopoietic cell transplantation (HCT). Elevations in follistatin plasma concentrations are associated with the onset of and poor survival after acute graft versus host disease (aGVHD). Using data from the Blood and M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Turcotte, Lucie M., DeFor, Todd E., Newell, Laura F., Cutler, Corey S., Verneris, Michael R., Wu, Juan, Howard, Alan, MacMillan, Margaret L., Antin, Joseph H., Vercellotti, Gregory M., Slungaard, Arne, Blazar, Bruce R., Weisdorf, Daniel J., Panoskaltsis-Mortari, Angela, Holtan, Shernan G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752567/ https://www.ncbi.nlm.nih.gov/pubmed/29058696 http://dx.doi.org/10.1038/bmt.2017.236

Ejemplares similares

High cutaneous amphiregulin expression predicts fatal acute graft‐versus‐host disease
por: Schultz, Brittney, et al.
Publicado: (2022)

Validation of Minnesota acute graft-versus-host disease Risk Score
por: MacMillan, Margaret L., et al.
Publicado: (2020)

High incidence of thromboembolism in patients with chronic GVHD: association with severity of GVHD and donor-recipient ABO blood group
por: El Jurdi, Najla, et al.
Publicado: (2021)

Transient regulatory T-cell (Treg) depletion with IL-2 diphtheria toxin fusion protein enhances clearance of acute myeloid leukemia by haploidentical natural killer (NK) cells
por: Bachanova, Veronika, et al.
Publicado: (2013)

P04.02. An Integrative Approach to Fertility and Preconception Care
por: Maker-Clark, Geeta, et al.
Publicado: (2013)

Chronic GVHD after steroid-sensitive, -dependent, and -refractory acute GVHD: incidence and clinical outcomes
por: Herzog, Shannon, et al.
Publicado: (2023)

Lymphodepleting chemotherapy with donor lymphocyte infusion post-allogeneic HCT for hematological malignancies is associated with severe, but therapy-responsive aGVHD
por: He, Fiona, et al.
Publicado: (2016)

Factors Predicting Single-Unit Predominance after Double Umbilical Cord Blood Transplantation
por: Ramirez, Pablo, et al.
Publicado: (2011)

Phase II Study of Myeloablative 8/8- or 7/8-Matched Allotransplantation with Post-Transplant Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil: Marked Reduction in GVHD Risk Without Increased Relapse Risk Compared to Historical Cyclosporine/Methotrexate
por: El Jurdi, Najla, et al.
Publicado: (2023)

OA04.02. Mechanisms of growth inhibition of pancreatic cancer by omega-3 polyunsaturated fatty acids
por: Chen, M, et al.
Publicado: (2012)

Dysbiosis patterns during re-induction/salvage versus induction chemotherapy for acute leukemia
por: Rashidi, Armin, et al.
Publicado: (2019)

CD56(dim)CD57(+)NKG2C(+) NK cell expansion is associated with reduced leukemia relapse after reduced intensity HCT
por: Cichocki, Frank, et al.
Publicado: (2015)

Graft-versus-host disease: teaching old drugs new tricks at less cost
por: Farhan, Shatha, et al.
Publicado: (2023)

Whole-Body Distribution of Leukemia and Functional Total Marrow Irradiation Based on FLT-PET and Dual-Energy CT
por: Magome, Taiki, et al.
Publicado: (2017)

75200 Fecal Microbiota Transplantation to Prevent Infections in Patients with Acute Myeloid Leukemia: A Double-Blind Randomized Placebo-Controlled Phase 2 Clinical Trial
por: Ebadi, Armin Rashidiryam, et al.
Publicado: (2021)

Loss of Sex and Age Driven Differences in the Gut Microbiome Characterize Arthritis-Susceptible *0401 Mice but Not Arthritis-Resistant *0402 Mice
por: Gomez, Andres, et al.
Publicado: (2012)

P04.02. How familiar are infectious disease (ID) physicians with integrative medicine (IM) modalities and are they willing to recommend them?
por: Shere-Wolfe, K, et al.
Publicado: (2012)

Cd47 (Integrin-Associated Protein) Engagement of Dendritic Cell and Macrophage Counterreceptors Is Required to Prevent the Clearance of Donor Lymphohematopoietic Cells
por: Blazar, Bruce R., et al.
Publicado: (2001)

Human Effectors of Acute and Chronic GVHD Overexpress CD83 and Predict Mortality
por: Holtan, Shernan G., et al.
Publicado: (2023)

Higher Therapeutic Cyclosporine Levels Early Post-Transplantation Reduces Risks of Acute Graft-Versus-Host Disease and Improves Survival
por: Rogosheske, John R., et al.
Publicado: (2013)

Gut microbiota response to antibiotics is personalized and depends on baseline microbiota
por: Rashidi, Armin, et al.
Publicado: (2021)

Effect of COVID-19 precautions on the gut microbiota and nosocomial infections
por: Rashidi, Armin, et al.
Publicado: (2021)

Loss of microbiota-derived protective metabolites after neutropenic fever
por: Rashidi, Armin, et al.
Publicado: (2022)

Compilation of longitudinal gut microbiome, serum metabolome, and clinical data in acute myeloid leukemia
por: Rashidi, Armin, et al.
Publicado: (2022)

Lasting shift in the gut microbiota in patients with acute myeloid leukemia
por: Rashidi, Armin, et al.
Publicado: (2022)

Follistatin and the Breast Implant Capsule
por: Frenkiel, Brett A., et al.
Publicado: (2017)

Analysis of memory T lymphocyte activity following stimulation with overlapping HLA-A*2402, A*0101 and Cw*0402 restricted CMV pp65 peptides
por: Ghei, Monica, et al.
Publicado: (2005)

Life-Threatening Hypertriglyceridemia in a Patient on Ruxolitinib and Sirolimus for Chronic Graft-versus-Host Disease
por: Watson, Allison P., et al.
Publicado: (2018)

Vancomycin-resistance gene cluster, vanC, in the gut microbiome of acute leukemia patients undergoing intensive chemotherapy
por: Rashidi, Armin, et al.
Publicado: (2019)

Altered microbiota-host metabolic cross talk preceding neutropenic fever in patients with acute leukemia
por: Rashidi, Armin, et al.
Publicado: (2021)

Early E. casseliflavus gut colonization and outcomes of allogeneic hematopoietic cell transplantation
por: Rashidi, Armin, et al.
Publicado: (2019)

Inactivating hepatic follistatin alleviates hyperglycemia
por: Tao, Rongya, et al.
Publicado: (2018)

Do Cancer and Cancer Treatments Accelerate Aging?
por: Bhatia, Roma, et al.
Publicado: (2022)

Serum Activin A and Follistatin Levels in Gestational Diabetes and the Association of the Activin A-Follistatin System with Anthropometric Parameters in Offspring
por: Näf, Silvia, et al.
Publicado: (2014)

Are follistatin-like protein 1 and follistatin-like protein 3 associated with inflammatory processes in patients with familial Mediterranean fever?
por: Kaplan, Huseyin, et al.
Publicado: (2023)

Follistatin-like 1 in development and human diseases
por: Mattiotti, Andrea, et al.
Publicado: (2018)

Assessment of a multi-cytokine profile by a novel biochip-based assay allows correlation of cytokine profiles with clinical outcomes in adult recipients of umbilical cord blood transplantation
por: Karantanos, Theodoros, et al.
Publicado: (2019)

Growth Differentiation Factor 9 (GDF9) Suppresses Follistatin and Follistatin-Like 3 Production in Human Granulosa-Lutein Cells
por: Shi, Feng-Tao, et al.
Publicado: (2011)

Infections in Recipients of Hematopoietic Stem Cell Transplants
por: Young, Jo-Anne H., et al.
Publicado: (2015)

Immune Reactivation by Cell-Free Fetal DNA in Healthy Pregnancies Re-Purposed to Target Tumors: Novel Checkpoint Inhibition in Cancer Therapeutics
por: Enninga, Elizabeth Ann L., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_pfq9qdvffd95g6q1i9snp7jfi8